The Relationship Between Erythrocyte Transfusion and Nutrition and Necrotizing Enterocolitis in Preterm Infants
NCT ID: NCT04083638
Last Updated: 2019-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
81 participants
OBSERVATIONAL
2020-01-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis
NCT04921696
Withholding Feeds During Red Blood Cell Transfusion and TRAGI
NCT02132819
Impact of Enteral Feeding on Splanchnic Oxygenation During Packed Red Blood Cell Transfusion in Preterm Infants
NCT06632314
RBC Irradiation, Anemia and Gut Injury
NCT02741648
Blood Transfusions in Preterm Infants
NCT05331235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Control group
IFAB
Intestinal Fatty Acid Binding Protein will be taken from all participants before the tx and after the tx
Group 2
Feeding will not stop during the transfusion
IFAB
Intestinal Fatty Acid Binding Protein will be taken from all participants before the tx and after the tx
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IFAB
Intestinal Fatty Acid Binding Protein will be taken from all participants before the tx and after the tx
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Month
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Behcet Uz Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Senem Alkan Özdemir
MD, Associate Professor of Neonatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rüya Çolak, MD
Role: STUDY_CHAIR
Behcet Uz Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Behçet Uz Children's Hospital
İzmirli, İzmir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/279
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.